Biomelogic
Press kit

Biomelogic press kit.

For journalists, podcast hosts, editors, and conference organizers. Bios, headshots, logos, speaking topics, and sample questions for Mohammed Attallah and Biomelogic.

Booking and press inquiries: research@biomelogic.net

Short bio (60 words)

Mohammed Attallah is an independent systems-biology researcher and founder of Biomelogic. He developed the Host Capacity Model — a framework that reframes recurrent SIBO, MCAS, long COVID, and chronic dysbiosis as downstream of colonocyte bioenergetic failure. He works alongside clients' medical teams, providing mechanistic analysis. He is not a licensed clinician. biomelogic.net.

Long bio (200 words)

Mohammed Attallah is an independent systems-biology researcher and the founder of Biomelogic, a consulting practice based in Maryland that applies mechanistic analysis to complex chronic conditions including recurrent SIBO, MCAS, long COVID, hEDS–POTS–MCAS overlap, and chronic dysbiosis.

He is the developer of the Host Capacity Model, a unified framework that reframes these conditions as downstream of colonocyte bioenergetic failure rather than primary microbial dysbiosis. His work focuses on the CD38–NAD+–SIRT3 cascade, SLC5A8 epigenetic silencing, and iron-sulfur cluster insufficiency as the proximate mechanisms producing the clinical phenotypes recognized as chronic gut, mast cell, and post-viral illness.

Mohammed is not a licensed clinician; his consulting work is educational systems-biology analysis that operates alongside his clients' licensed medical teams. He collaborates with Dr. Christine Houghton (Cell-Logic, Australia) on framework development and manuscript preparation. His writing appears on Biomelogic, Substack, and Medium. He lives in Bowie, Maryland with his family.

Contact: research@biomelogic.net. Website: biomelogic.net.

Topics Mohammed can speak on

  • Why standard SIBO treatment produces recurrence — and what the underlying biology says to do instead
  • Stratifying MCAS into four mechanistically distinct patterns
  • The metabolic biology of long COVID and post-viral gut–immune dysfunction
  • Colonocyte bioenergetic failure as the proximate cause of chronic dysbiosis
  • The CD38–NAD+–SIRT3 cascade in chronic illness
  • SLC5A8 epigenetic silencing and the loss of butyrate oxidation
  • Iron-sulfur cluster insufficiency and mitochondrial fragility
  • The hEDS–POTS–MCAS overlap through a single mechanistic frame
  • Reframing dysbiosis as ecological failure of the colonic habitat
  • How an independent systems-biology consultant collaborates with licensed clinicians
  • What an evidence-tiered, claim-ledgered consulting practice looks like
  • The Host Capacity Model: building a unified framework outside academia

Sample interview questions

  • What is the Host Capacity Model in one paragraph?
  • Why does SIBO keep coming back after rifaximin in so many patients?
  • How do you distinguish four different patterns of mast cell activation?
  • What changes when you treat chronic illness as bioenergetic rather than infectious?
  • What does collaboration with licensed clinicians look like in your practice?
  • What's the single most under-recognized mechanism in chronic gut illness?
  • Where does the Host Capacity Model converge with — and depart from — mainstream gastroenterology?
  • What would you want a primary care physician to know in 5 minutes?

Visual assets

Headshots, the Biomelogic logo, and framework diagrams are available for editorial use with attribution to "Mohammed Attallah / Biomelogic · biomelogic.net". Full library and downloadable files on the visual asset library.

For high-resolution headshots not currently published, email research@biomelogic.net and we will send them directly.

Background and references

Editorial scope note

Biomelogic is educational systems-biology consulting. It does not diagnose, treat, prescribe, triage urgent symptoms, or replace licensed medical care. Please preserve this scope when quoting or summarizing.